Patient and Provider Assessment of Lipid Management Registry

Inclusion Criteria:

1. Prior evidence of clinical atherosclerotic cardiovascular disease (ASCVD) which can include any of the following:

* Hospitalization for acute myocardial infarction or unstable angina

* Coronary revascularization or chronic coronary artery disease with or without angina

* Other arterial (carotid, abdominal, renal or lower extremity) revascularization (e.g., surgical bypass, percutaneous intervention, arterial vascular reconstruction, abdominal aortic aneurysm repair, excluding dialysis fistulas or arteriovenous grafts).

* Ischemic stroke or transient ischemic attack (TIA)

* Imaging evidence of > 70% diameter stenosis in any carotid artery or clinical documentation of severe carotid stenosis

* Peripheral arterial disease secondary to atherosclerosis (e.g., aortic aneurysm, ankle brachial index <0.9, imaging evidence of >50% diameter stenosis in any peripheral artery, or claudication)

2. Currently on statin therapy

3. Low density lipoprotein cholesterol (LDL-C) level ≥ 130 mg/dL within the last 2 years (treated or untreated)

4. Age ≥ 65 years

5. Age ≥ 40 years with at least 1 of the following:

* Diabetes

* Chronic Kidney Disease (CKD), defined as eGFR <60 ml/min or documented stage III or higher CKD

* 10-year ASCVD risk ≥ 5% (per the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk)

* 2 or more of the following characteristics: Male sex; Systolic BP > 140 mmHg or on medication for hypertension; Current tobacco use

Exclusion Criteria:

1. Unable or unwilling to provide informed consent, including but not limited to cognitive or language barriers (reading or comprehension)

2. Anticipated life expectancy less than 6 months

3. Participation in any clinical trial involving a medical treatment at the time of enrollment